Detailed Findings
Geographies and Sectors
0%
54% select Mid- and Small-Cal Pharma & Biotech to be the best-performing healthcare sub-sector in 2025
Best Performing Sub-Sectors
Developments in the market have changed the sub-sectors which respondents see as most likely to perform best in the year ahead. Mid- and Small-Cap Pharma & Biotech is where investors see the greatest opportunity (54%). It benefits from a shared confident outlook from Institutional Investors, Private Equity and Healthcare Corporates themselves.
The outlook for Large Cap Pharma is much more muted, with only 15% selecting it as the most likely sub-sector to perform best. Versus last year, Tools and Diagnostics has come off the boil, from 13% viewing it favourably to just 5% this year.
Healthcare IT is one to watch, increasing from 7% to 12% in this year’s report, showing a positive trajectory.
Jefferies Financial Group Inc. is the largest independent, global, full-service investment banking and capital markets firm headquartered in the United States. Focused on serving clients for nearly 60 years, Jefferies is a leader in providing insight, expertise and execution to investors, companies and governments. Our firm provides a full range of investment banking, advisory, sales and trading, research and wealth management services across all products in the Americas, Europe and Asia. www.jefferies.com
IMPORTANT: You must read the following before reading, accessing or making any other use of this publication. In accessing this publication, you agree to be bound by the following terms and conditions. This document is being furnished for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to purchase any security or other financial instrument or product. It is not intended to form the basis of any investment decision. Jefferies International Limited and its affiliates (together “Jefferies”) makes no representation as to the accuracy or completeness of the information contained herein or any other information, whether written or oral, made available. Jefferies disclaims all and any liability whatsoever, whether arising in tort, contract or otherwise, for the contents of this publication. You acknowledge that Jefferies does not owe you or any other person or entity, any fiduciary or similar duty as a result of the publication of this report, and Jefferies is not providing any advice, including with respect to legal, tax, accounting, investment or regulatory matters, in any jurisdiction.
